Blood Flow Regulation in Individuals With Down Syndrome - Training Study
Key facts
- Who runs it
- University of Nevada, Las Vegas
- Where
- Las Vegas, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 9 Sept 2021
- Ended
- 31 Aug 2024
- Type of study
- Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Combined exercise intervention
- Usual care / Sham intervention
- Record updated
- 4 February 2026
Who can take part
- Age
- 18 years to 35 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- generally healthy
- sedentary (defined as being involved in less than 30 minutes of moderately-intense physical activity per day)
- additionally for the participants with Down syndrome:
- diagnosis of Down syndrome trisomy 21 and
- normal thyroid function or stable thyroid function (and medications) for at least 6 mo
Who cannot take part
- anti-inflammatory medication including NSAIDS
- congenital heart disease
- atherosclerotic or other vascular disease
- asthma or other pulmonary disease
- hypertension (defined BP >140/90 mmHg)
- history of pre-syncope or syncope
- medications affecting heart rate, blood pressure or arterial function
- diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication)
- blood pressure below 90/60 mmHg
- severe obesity (defined as BMI >40)
- current smoking and
- pregnancy
Where in United States
- University of Nevada Las VegasLas Vegas, United States
About the trial
What the trial wants to find out
Work capacity is an important predictor of declining health or physical function, and of mortality, and is commonly measured as peak oxygen consumption. Peak oxygen consumption is very low in individuals with Down syndrome, the most prevalent genetic cause of intellectual disability. Previous research suggests individuals with Down syndrome may experience a double disadvantage when they are exercising: they may not be able to increase cardiac output sufficiently and they may not be able to allocate adequate blood flow to the working muscles. The aim of this research proposal is therefore to investigate the responses in central and peripheral blood flow regulation and cardiac autonomic function to exercise training in individuals with DS. Additionally the effects of exercise on gait, balance and attitude towards exercise in individuals with DS are investigated.
The 3 groups in the trial
- Combined exercise intervention Down syndromeTreatment being tested
The exercise intervention will last 12 weeks and will consist of a supervised combined aerobic and resistance training program with a frequency of 3 days/week.In the exercise sessions, the participant will work with the trainer on their strength, balance and aerobic endurance. Each session consists of 10 min of strength exercises (Foundational Exercise), 10 min of Hip Strengthening, 10 min of Vestibular and Balance Exercise, and 20 min of Aerobic Exercise, and starts with a warming up and ends with stretching/cooling down. Each new exercise will be introduced in easy steps and practiced until the participant is comfortable executing it.
Treatment: Combined exercise intervention
- Usual care Down SyndromeSham treatment, for comparison
The control condition consists of usual activities.
Treatment: Usual care / Sham intervention
- Reference group without Down syndromeNo study treatment, for comparison
This reference group of age- and sex-matched inactive individuals without Down syndrome will undergo the same baseline testing as the other groups but without intervention or post-intervention measures.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Exercise Training on Central and Peripheral Blood Flow Regulation in Individuals With Down Syndrome
- Record updated
- 4 February 2026